Uzuegbunam, B.C.; Li, J.; Paslawski, W.; Weber, W.; Svenningsson, P.; Ã…gren, H.; Hooshyar Yousefi, B.
In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker. Int. J. Mol. Sci. 2023, 24, 16445.
https://doi.org/10.3390/ijms242216445
AMA Style
Uzuegbunam BC, Li J, Paslawski W, Weber W, Svenningsson P, Ã…gren H, Hooshyar Yousefi B.
In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker. International Journal of Molecular Sciences. 2023; 24(22):16445.
https://doi.org/10.3390/ijms242216445
Chicago/Turabian Style
Uzuegbunam, Bright C., Junhao Li, Wojciech Paslawski, Wolfgang Weber, Per Svenningsson, Hans Ã…gren, and Behrooz Hooshyar Yousefi.
2023. "In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker" International Journal of Molecular Sciences 24, no. 22: 16445.
https://doi.org/10.3390/ijms242216445
APA Style
Uzuegbunam, B. C., Li, J., Paslawski, W., Weber, W., Svenningsson, P., Ã…gren, H., & Hooshyar Yousefi, B.
(2023). In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker. International Journal of Molecular Sciences, 24(22), 16445.
https://doi.org/10.3390/ijms242216445